Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6856)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2018 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P, Wittkop L, ANRS CO13 Hepavih study Group. Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients. World J Hepatol 2018; 10(11): 856-866 [PMID: 30533186 DOI: 10.4254/wjh.v10.i11.856] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i11/856.htm |
| Number | Citing Articles |
| 1 |
Benedikt Bernhard, Felix Stickel. Successful fourth line treatment of a relapse patient with chronic hepatitis C virus infection genotype 3a using sofosbuvir, glecaprevir/pibrentasvir, and ribavirin: a case report. Zeitschrift für Gastroenterologie 2020; 58(05): 451 doi: 10.1055/a-1131-8058
|
| 2 |
Ulrik Fahnøe, Martin S. Pedersen, Christina Sølund, Anja Ernst, Henrik B. Krarup, Birgit T. Røge, Peer B. Christensen, Alex L. Laursen, Jan Gerstoft, Peter Thielsen, Lone G. Madsen, Anders G. Pedersen, Kristian Schønning, Nina Weis, Jens Bukh. Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non‐target sites, for DAA‐based treatment and retreatment outcome. Journal of Viral Hepatitis 2021; 28(2): 302 doi: 10.1111/jvh.13430
|
| 3 |
Kazem Baesi, Ali Akbar Velayati, Masoumeh Farrokh Ashtiani, Kamal Fakhredini, Mohammad Banifazl, Mona Sadat Larijani, Parya Basimi, Amitis Ramezani. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients. Current HIV Research 2021; 19(5): 391 doi: 10.2174/1566523221666210707142838
|
| 4 |
Nipun Jain, Ravinder Garg, Gagan Preet Singh, Sarabjot Kaur, Sumit Pal Singh Chawla, Preeti Padda. Assessment of Factors Affecting Response of Direct-Acting Antivirals in Chronic Hepatitis C Patients. Annals of African Medicine 2023; 22(4): 456 doi: 10.4103/aam.aam_183_22
|
| 5 |
Sudhamshu KC, Holly Murphy, Sameer Dixit, Apurva Rai, Bickram Pradhan, Marie Lagrange-Xelot, Niyanta Karki, Amélie Dureault, Ujjwal Karmacharya, Santosh Panthi, Nabin Tulachan, Prawchan KC, Anjay KC, Rajesh Rajbhandari, Andrew B. Trotter, Jörg Gölz, Pierre Pradat, Christian Trépo, Philippe Creac'H, Alexander Stockdale. Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal. PLOS Neglected Tropical Diseases 2020; 14(12): e0008931 doi: 10.1371/journal.pntd.0008931
|
| 6 |
Ekta Gupta, Reshu Agarwal, Aayushi Rastogi, Nitiksha Rani, Ankur Jindal. Naturally Occurring Resistance Associated Substitutions in Non-Cirrhotic, Treatment Naive HCV–HIV Co-Infected Patients Does Not Affect the Treatment Response for Anti-HCV Antiviral Therapy. Infection and Drug Resistance 2021; : 1381 doi: 10.2147/IDR.S301032
|
| 7 |
Georgios Angelidakis, Haley Pritchard, Marcel Yibirin, Ying Jiang, Khalis Mustafayev, Harrys A. Torres. Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational study. Diagnostic Microbiology and Infectious Disease 2022; 103(3): 115719 doi: 10.1016/j.diagmicrobio.2022.115719
|
| 8 |
Ewa Janczewska, Mateusz Franciszek Kołek, Beata Lorenc, Jakub Klapaczyński, Magdalena Tudrujek-Zdunek, Marek Sitko, Włodzimierz Mazur, Dorota Zarębska-Michaluk, Iwona Buczyńska, Dorota Dybowska, Agnieszka Czauż-Andrzejuk, Hanna Berak, Rafał Krygier, Jerzy Jaroszewicz, Jolanta Citko, Anna Piekarska, Beata Dobracka, Łukasz Socha, Zbigniew Deroń, Łukasz Laurans, Jolanta Białkowska-Warzecha, Olga Tronina, Brygida Adamek, Krzysztof Tomasiewicz, Krzysztof Simon, Malgorzata Pawłowska, Waldemar Halota, Robert Flisiak. Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study. World Journal of Gastroenterology 2021; 27(18): 2177-2192 doi: 10.3748/wjg.v27.i18.2177
|